---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-023445"
form_type: "8-K"
ticker: "CJMB"
cik: "0002032545"
company_name: "CALLAN JMB INC."
filed_at: "2025-11-14T23:59:59+00:00"
generated_at: "2026-05-16T19:58:16.788063+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Callan JMB Q3 revenue $1.4M, operating loss $1.9M; expands into food sampling and India

## Summary
- Revenue $1.4M Q3, $4.6M YTD; operating loss $1.9M Q3, $4.5M YTD.
- Entered food sampling sector; signed preliminary agreement for oral drug delivery equipment at Texas cGMP facility.
- Formed Indian subsidiary for pharma storage; extended Chicago contract to June 2026 with $1.5M increase ($9.1M total).
- Upgraded Sentry Monitoring System to v4.0 with HTML5 for web-based temperature monitoring.
- SG&A rose to $2.4M Q3 from public listing costs; cash at $2.8M.

## SEC filing metadata
- accession: 0001493152-25-023445
- form_type: 8-K
- ticker: CJMB
- cik: 0002032545
- company_name: CALLAN JMB INC.
- filed_at: 2025-11-14T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2032545/000149315225023445/0001493152-25-023445-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2032545/000149315225023445/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-023445
- JSON: https://secwatch.observer/filing/0001493152-25-023445.json
- Plain text: https://secwatch.observer/filing/0001493152-25-023445.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.